Dr Sosunmolu Opememi Shoyinka, MD, MBA - Medicare Psychiatry in Media, PA

Dr Sosunmolu Opememi Shoyinka, MD, MBA is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Media, Pennsylvania. He graduated from medical school in 1999 and has 25 years of diverse experience with area of expertise as Psychiatry. He is a member of the group practice Montgomery County Mh-mr Emergency Service and his current practice location is 42 E Front Street, Media, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (917) 589-4879.

Dr Sosunmolu Opememi Shoyinka is licensed to practice in Pennsylvania (license number MD468458) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1811181696.

Contact Information

Dr Sosunmolu Opememi Shoyinka, MD, MBA
42 E Front Street,
Media, PA 19063
(917) 589-4879
(573) 884-4515



Physician's Profile

Full NameDr Sosunmolu Opememi Shoyinka
GenderMale
SpecialityPsychiatry
Experience25 Years
Location42 E Front Street, Media, Pennsylvania
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Sosunmolu Opememi Shoyinka graduated from medical school in 1999
  NPI Data:
  • NPI Number: 1811181696
  • Provider Enumeration Date: 09/05/2007
  • Last Update Date: 09/19/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 4385760461
  • Enrollment ID: I20200207000261

Medical Identifiers

Medical identifiers for Dr Sosunmolu Opememi Shoyinka such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1811181696NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 4301500734 (Michigan)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 0437211 (Kansas)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 20693 (North Dakota)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 61826 (Arizona)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 2010014088 (Missouri)Secondary
390200000XStudent In An Organized Health Care Education/training Program (* (Not Available))Secondary
2084P0800XPsychiatry & Neurology - Psychiatry MD468458 (Pennsylvania)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Crozer Chester Medical CenterUpland, PAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Montgomery County Mh-mr Emergency Service327443526815

News Archive

Study assesses accuracy of COPD diagnoses and utilization of spirometry in primary care clinics

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors.

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin's Lymphoma

Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.

Genetically engineered mosquitoes to be released in Florida Keys

Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.

AstraZeneca receives 2010 EcoLeadership Award for second consecutive year

AstraZeneca announced today it has received the 2010 EcoLeadership Award by the Alliance for Workplace Excellence for the second consecutive year. The EcoLeadership Award recognizes companies that demonstrate their commitment to environmental sustainability practices such as energy efficiency, waste minimization and water conservation.

Boston Scientific introduces NLI online resource center for healthcare providers

Boston Scientific Corporation has launched its Neuromodulation Learning Institute (NLI), a clinical education program and online resource center for healthcare providers to enhance their knowledge and awareness of spinal cord stimulation (SCS) technology, procedures and techniques.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Sosunmolu Opememi Shoyinka allows following entities to bill medicare on his behalf.
Entity NameMontgomery County Mh-mr Emergency Service
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1386637734
PECOS PAC ID: 3274435268
Enrollment ID: O20040121000644

News Archive

Study assesses accuracy of COPD diagnoses and utilization of spirometry in primary care clinics

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors.

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin's Lymphoma

Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.

Genetically engineered mosquitoes to be released in Florida Keys

Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.

AstraZeneca receives 2010 EcoLeadership Award for second consecutive year

AstraZeneca announced today it has received the 2010 EcoLeadership Award by the Alliance for Workplace Excellence for the second consecutive year. The EcoLeadership Award recognizes companies that demonstrate their commitment to environmental sustainability practices such as energy efficiency, waste minimization and water conservation.

Boston Scientific introduces NLI online resource center for healthcare providers

Boston Scientific Corporation has launched its Neuromodulation Learning Institute (NLI), a clinical education program and online resource center for healthcare providers to enhance their knowledge and awareness of spinal cord stimulation (SCS) technology, procedures and techniques.

Read more Medical News

› Verified 4 days ago

Entity NameProspect Health Access Network Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568819084
PECOS PAC ID: 5698065142
Enrollment ID: O20160613000737

News Archive

Study assesses accuracy of COPD diagnoses and utilization of spirometry in primary care clinics

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors.

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin's Lymphoma

Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.

Genetically engineered mosquitoes to be released in Florida Keys

Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.

AstraZeneca receives 2010 EcoLeadership Award for second consecutive year

AstraZeneca announced today it has received the 2010 EcoLeadership Award by the Alliance for Workplace Excellence for the second consecutive year. The EcoLeadership Award recognizes companies that demonstrate their commitment to environmental sustainability practices such as energy efficiency, waste minimization and water conservation.

Boston Scientific introduces NLI online resource center for healthcare providers

Boston Scientific Corporation has launched its Neuromodulation Learning Institute (NLI), a clinical education program and online resource center for healthcare providers to enhance their knowledge and awareness of spinal cord stimulation (SCS) technology, procedures and techniques.

Read more Medical News

› Verified 4 days ago

Entity NameCentia Health Pennsylvania Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952052409
PECOS PAC ID: 7517353329
Enrollment ID: O20220404002412

News Archive

Study assesses accuracy of COPD diagnoses and utilization of spirometry in primary care clinics

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors.

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin's Lymphoma

Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.

Genetically engineered mosquitoes to be released in Florida Keys

Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.

AstraZeneca receives 2010 EcoLeadership Award for second consecutive year

AstraZeneca announced today it has received the 2010 EcoLeadership Award by the Alliance for Workplace Excellence for the second consecutive year. The EcoLeadership Award recognizes companies that demonstrate their commitment to environmental sustainability practices such as energy efficiency, waste minimization and water conservation.

Boston Scientific introduces NLI online resource center for healthcare providers

Boston Scientific Corporation has launched its Neuromodulation Learning Institute (NLI), a clinical education program and online resource center for healthcare providers to enhance their knowledge and awareness of spinal cord stimulation (SCS) technology, procedures and techniques.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Sosunmolu Opememi Shoyinka is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Sosunmolu Opememi Shoyinka, MD, MBA
36 E Front St,
Media, PA 19063-2936

Ph: (917) 589-4879
Dr Sosunmolu Opememi Shoyinka, MD, MBA
42 E Front Street,
Media, PA 19063

Ph: (917) 589-4879

News Archive

Study assesses accuracy of COPD diagnoses and utilization of spirometry in primary care clinics

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors.

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin's Lymphoma

Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.

Genetically engineered mosquitoes to be released in Florida Keys

Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.

AstraZeneca receives 2010 EcoLeadership Award for second consecutive year

AstraZeneca announced today it has received the 2010 EcoLeadership Award by the Alliance for Workplace Excellence for the second consecutive year. The EcoLeadership Award recognizes companies that demonstrate their commitment to environmental sustainability practices such as energy efficiency, waste minimization and water conservation.

Boston Scientific introduces NLI online resource center for healthcare providers

Boston Scientific Corporation has launched its Neuromodulation Learning Institute (NLI), a clinical education program and online resource center for healthcare providers to enhance their knowledge and awareness of spinal cord stimulation (SCS) technology, procedures and techniques.

Read more News

› Verified 4 days ago


Psychiatry & Neurology Doctors in Media, PA

Dr. Pamela Rootenberg, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 35 Indian Spring Rd, Media, PA 19063
Phone: 610-891-9352    
William Joseph Hernz, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 19 E Second St, First Floor, Media, PA 19063
Phone: 610-565-3587    Fax: 610-566-1287
Dr. David A Thomas, DO, PH.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1088 W Baltimore Pike, Hcii Suite 2205, Media, PA 19063
Phone: 610-744-2960    Fax: 610-744-2420
Dr. William J Oberfield, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 19 E Second St, Media, PA 19063
Phone: 610-565-9560    Fax: 610-565-8011
Ms. Regina May Showell, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 618 S. Old Middletown Road, Media, PA 19063
Phone: 610-872-1416    Fax: 610-872-1416
Patricia Kent, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 100 W Sixth St Ste 303, Media, PA 19063
Phone: 610-566-0172    
Dr. Patrick Cleary, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 714 Hemlock Rd, Media, PA 19063
Phone: 267-753-0613    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.